Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00002848 · ClinicalTrials.gov registry record · NA

Group Therapy Compared With Educational Materials in Patients With Prostate Cancer

A NA study of Prostate Cancer and Psychosocial Effects of Cancer and Its Treatment, sponsored by Gary Morrow.

Completed
Registry status
NA
Development phase
480
Enrollment target
7
Study locations

NCT00002848: Completed NA study of Prostate Cancer and Psychosocial Effects of Cancer and Its Treatment, sponsored by Gary Morrow.

NCT00002848 is a NA study of Prostate Cancer and Psychosocial Effects of Cancer and Its Treatment that has completed, run by Gary Morrow. The registered enrollment target is 480 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (21% lower). The trial reports 7 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00002848, a NA study of Prostate Cancer and Psychosocial Effects of Cancer and Its Treatment, has completed, sponsored by Gary Morrow.

COMPLETED
Registry status
NA
Development phase
480 participants
Enrollment target
7
Study locations

Study Summary

RATIONALE: Developing coping strategies may help improve the quality of life of patients with prostate cancer. PURPOSE: This randomized clinical trial is comparing the effect of group therapy with written educational materials on the quality of life of men with stage I or stage II prostate cancer.

Interventions

  • PROCEDURE quality-of-life assessment
  • PROCEDURE psychosocial assessment and care

Study Locations (7)

Arizona

  • CCOP - Western Regional, Arizona - Phoenix

California

  • Stanford Cancer Center at Stanford University Medical Center - Stanford

Kansas

  • CCOP - Wichita - Wichita

Michigan

  • CCOP - Kalamazoo - Kalamazoo

New York

  • James P. Wilmot Cancer Center at University of Rochester Medical Center - Rochester

Ohio

  • CCOP - Columbus - Columbus

Washington

  • CCOP - Northwest - Tacoma

Trial Details

FieldValue
Enrollment Target 480 participants
Start Date 1997-04
Est. Completion 2004-09
Phase NA
Gary Morrow

16 total trials

What the finished NCT00002848 record still lists

NCT00002848 is an interventional study that assigns participants to a tested intervention. The registered 480 participants enrollment target is mid-sized for trials with a published cap, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (21% lower).

The record links to 2 conditions, with Prostate Cancer appearing as the primary indexed condition, and to 2 interventions - of which quality-of-life assessment is the first listed.

NCT00002848 lists 7 locations in 7 states (Arizona, California, Kansas).

Frequently Asked Questions

What is clinical trial NCT00002848 about?

NCT00002848 is a clinical study titled "Group Therapy Compared With Educational Materials in Patients With Prostate Cancer". RATIONALE: Developing coping strategies may help improve the quality of life of patients with prostate cancer. PURPOSE: This randomized clinical trial is comparing the effect of group therapy with written educational materials on the quality of life of men with stage I or stage II prostate cancer.

What is the current status of trial NCT00002848?

This trial is currently completed. It is a NA study. The enrollment target is 480 participants. The study started on 1997-04. Estimated completion is 2004-09.

What conditions does trial NCT00002848 study?

This clinical trial studies the following conditions: Prostate Cancer, Psychosocial Effects of Cancer and Its Treatment.

What interventions are being tested in trial NCT00002848?

The interventions under investigation include: quality-of-life assessment (PROCEDURE), psychosocial assessment and care (PROCEDURE).

Who is sponsoring clinical trial NCT00002848?

This trial is sponsored by Gary Morrow, which has 16 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00002848 being conducted?

This trial has 7 study locations across Arizona, California, Kansas, Michigan, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Prostate Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00002848's enrollment target sits among peer trials

480 118th of 735 higher than 618 of 735 other Prostate Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Prostate Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01954992 · 480 participants · Phase 3

    Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer

  • NCT03023696 · 480 participants · NA

    Can Prophylactic Foraminotomy Prevent C5 Palsy

  • NCT04948060 · 480 participants · NA

    Tribally Engaged Approaches to Lung Screening (TEALS)

  • NCT05053230 · 480 participants · NA

    A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00002848, the US trial registry maintained by the National Library of Medicine. NCT00002848 (mid enrollment · multi site footprint · completed) retrieved and formatted by PlainTrial, see methodology.